The National Stem Cell Foundation, which is based in Louisville, has been awarded a $3.1 million grant from NASA to continue research on brain cell behavior in space as a way to find treatments and cures for neurogenerative conditions, and Kentucky is investing $300,000 toward the project as part of a 10% match.
Kentucky’s portion was allocated in the 2024 legislative session in Senate Bill 1. The announcement was made Wednesday, March 26 at the Kentucky State Capitol.
Pointing to the space research Kentucky students have done at the Craft Academy for Excellence in Science and Mathematics and NASA’s presence at Morehead State University, Senate President Robert Stivers, R-Manchester, said it was easy for him and his colleagues to support this type of research in hopes of making Kentucky a hub for it.
Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed.
Chalmers engineers built a pulse-driven qubit amplifier that’s ten times more efficient, stays cool, and safeguards quantum states—key for bigger, better quantum machines.
Our brains may work best when teetering on the edge of chaos. A new theory suggests that criticality a sweet spot between order and randomness is the secret to learning, memory, and adaptability. When brains drift from this state, diseases like Alzheimer s can take hold. Detecting and restoring criticality could transform diagnosis and treatment.
During sleep, the brain must achieve a delicate balance: disconnecting from sensory input to allow restorative functions, while remaining alert enough to wake if danger arises. How does it sort through external stimuli—particularly sounds—during sleep? Scientists from the University of Geneva (UNIGE) and the Institut Pasteur have studied how the brain responds to so-called “rough” sounds, such as screams or alarms.
They discovered that these sounds are systematically processed, unlike other sounds, triggering specific brain waves. These results, published in the journal Scientific Reports, provide a better understanding of certain perceptual disorders, such as hyperacusis (hypersensitivity and/or intolerance to certain sounds), as well as the impact of repeated nighttime disturbances on brain function.
Roughness is an acoustic property characterized by rapid modulations of sound intensity, between 40 and 100 times per second. “Unlike speech, where syllables occur at a rate between 4 and 8 Hz, rough sounds hit the auditory system at much higher frequencies, producing a shrill and often unpleasant sensation,” explains Luc Arnal, a researcher at the Institut Pasteur, who co-directed the study.
Scientists have built a compact physical qubit with built-in error correction, and now say it could be scaled into a 1,000-qubit machine that is small enough to fit inside a data center. They plan to release this machine in 2031.
The problem concerns the mathematical properties of solutions to the Navier–Stokes equations, a system of partial differential equations that describe the motion of a fluid in space. Solutions to the Navier–Stokes equations are used in many practical applications. However, theoretical understanding of the solutions to these equations is incomplete. In particular, solutions of the Navier–Stokes equations often include turbulence, which remains one of the greatest unsolved problems in physics, despite its immense importance in science and engineering.
*Apply to join Foresight Biotech & Health Extension program:* https://foresight.org/biotech-health-extension-program/ A group of scientists, entrepreneurs, funders, and institutional allies who cooperate to advance biotechnology to reverse aging and extend human healthspan. This group is sponsored by 100 Plus Capital. http://100pluscap.com/
*Foresights Personal Longevity Group* Exploring anti-aging methods, monthly virtual meetings, expert discussions, private group for Foresight Patrons. https://foresight.org/personal-longevity-group/
*Brad Younggren | Therapeutic Plasma Exchange (TPE): A Tool Against Aging and Disease* Bio: Brad Younggren, MD, is CEO and co-founder of Circulate Health, a company dedicated to extending human healthspan. A former U.S. Army physician, Dr. Younggren served as a combat physician in Iraq and was awarded a Bronze Star and Combat Medical Badge. An emergency medicine specialist and seasoned healthcare executive, Younggren has led teams at the cutting edge of medicine for decades. Most recently, he was President and Chief Medical Officer at 98point6, where he led the development and launch of AI-powered primary care solutions. He previously served as CMO at Cue Health, Shift Labs, and Mobisante. At Circulate, Younggren leads an expert team of clinicians and scientists working to harness the potential of therapeutic plasma exchange to advance health and longevity. https://www.circulate.health/
Abstract: Aging is the primary risk factor for most chronic diseases, driving over 90% of U.S. healthcare expenditures. However, emerging science suggests that aging itself can be targeted as a modifiable process. Therapeutic Plasma Exchange (TPE) is a promising intervention that removes harmful substances from the bloodstream, reducing inflammation, disease burden, and potentially reversing aspects of biological aging. Circulate Health is pioneering this space, with clinical trial data demonstrating measurable reductions in biological age and improvements in key biomarkers. Beyond its longevity benefits, recent findings suggest TPE may help reduce microplastics and other environmental toxins—offering a practical, scalable approach to mitigating modern health threats. In this talk, we’ll explore the science behind TPE, its clinical applications, and why Circulate Health’s model makes this groundbreaking treatment accessible to more patients and clinics.
